Analyst Ratings for Regeneron Pharma (REGN) [Buys]
REGN Rating Summary
REGN Price Target Summary
- Highest: $1,184.00 (RBC Capital)
- Lowest: $795.00 (Cantor Fitzgerald)
- Average: $1,031.53
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,031.53 (+7.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10 Percentile Rank: 72%
Rating Score: 6.7 / 10 Percentile Rank: 72%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/12/2024 | Bernstein | William Pickering | New Coverage | Outperform (N/A) |
1,125.00 (N/A) |
968.83 (959.92) |
-0.92% | Details |
1/12/2024 | RBC Capital » Updated 2/27/2024 |
Brian Abrahams | Upgrade | Outperform (Sector Perform) |
1,184.00 (1,096.00) |
915.97 (959.92) |
4.8% | Details |